compound semaglutide news versions of GLP-1 drugs for weight loss halted by FDA Compounded Semaglutide: What to Know

In der Schweiz sind fr die Behandlung der Adipositas mittlerweile zwei Wirkstoffe verfgbar: Der langwirksame GLP-1-RA Semaglutid , und der langwirksame duale Agonist des GLP-1-Rezeptors und des glukoseabhngigen insulinotropen-Peptid (GIP)-Rezeptors, Tirzepatid*

Pill versions may be available for some GLP-1 medications if you do not like or cannot take injections

Every dose from 2.5 mg through 15 mg fits comfortably within a 1 mL syringe, and even the maximum 15 mg dose only requires 75 units

Counsel patients to promptly seek medical attention if they develop pain or tenderness, redness, or swelling of the genitals or the area from the genitals back to the rectum, along with a fever above 100.4F or malaise [see Warnings and Precautions (5.6)]

There is a critical unmet need for effective pharmacotherapies that target the underlying metabolic and inflammatory mechanisms driving MASLD